Fig. 1.

Effect of high-dose intravenous rifampin on survival of Indonesian tuberculous meningitis patients (Reprinted from Lancet Infectious Diseases, Vol 13(1), Rovina Ruslami, A Rizal Ganiem, Sofiati Dian, Lika Apriani, Tri Hanggono Achmad, Andre J van der Ven, George Borm, Rob E Aarnoutse, Reinout van Crevel, Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial, page nos. 27–35, Copyright (2013), with permission from Elsevier)